◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Ono Pharmaceutical Co., Ltd. (4528)
来自官方财务报表的收入、利润与现金流历史。
Healthcare · 华尔街（美国） · 最近更新： 2026-10-02
Ono Pharmaceutical Co., Ltd. produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo intravenous infusion and Kyprolis intravenous injection for malignant tumors; Emend capsule intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; Mektovi, Velexbru, and Braftovi capsules for malignant tumors; and ADLUMIZ tablets for cancer cachexia.
关键数据
- 市值: JPY 1.08 trillion
- 收入（截至 2026-03-31 财年）: JPY 515.8B
- 净利润: JPY 69.8B
- 毛利率: 72.5%
- 净利率: 13.5%
查看交互式图表与完整报表 →
估值模型 (DCF) →
年度利润表
| 利润表 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|
| 总收入 | JPY 515.8B | JPY 486.9B | JPY 502.7B | JPY 447.2B |
| 毛利 | JPY 374.1B | JPY 338.9B | JPY 375.5B | JPY 337.1B |
| 营业利润（EBIT） | JPY 92.2B | JPY 59.7B | JPY 159.9B | JPY 142.0B |
| 净利 | JPY 69.8B | JPY 50.0B | JPY 128.0B | JPY 112.7B |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 4528 交互式查看器。 /companies/us/4528
类似公司
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.